ABOUT THIS EPISODE

English
United States

SHOW NOTES 🔗

TRANSCRIPT 🔗

SEARCH PAST EPISODES

Search past episodes of VJDementia Podcast.

OTHER EPISODES IN THIS PODCAST

On January 6, 2023, the US FDA approved lecanemab for the treatment of Alzheimer’s disease (AD), making history as the first ever treatment to significantly slow cognitive decline. Despite the excitement surrounding this breakthrough approval, concerns remain regarding the extent of lecanemab's cli…
In this episode, VJDementia are joined by Amy Lloyd, PhD, Soyon Hong, PhD, João Pedro Ferrari-Souza, MD-PhD student, & Elina Svensson, PhD student, who share their work looking at the roles of microglia in health and disease, and the implications of this for understanding how to treat Alzheimer…
In today’s episode, we hear from top researchers studying the retina as a window to the Alzheimer's brain. Hear the latest on retinal biomarkers, the development of a diagnostic 'eye test' for Alzheimer's disease, and the promise of retina organoids for novel drug development.  With Frederique Har…
Welcome to the VJSounds podcast, presented by the Video Journal of Dementia. In this episode, we dive into the latest advancements in Alzheimer's disease (AD) biomarkers, focusing on the diagnostic and predictive potential of plasma p-tau217. As an alternative to traditional PET assessment, blood-…
Disclaimer: The podcast and artwork embedded on this page are from vjdementia, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.